February 12, 2024 · Form 4 insider transaction
Atkinson Edward Morrow III sold 913 shares of Vertex Pharmaceuticals Incorporated at $420.24 per share, a transaction worth $383.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 8/22/2023.